AVIR Operating Expenses

Atea Pharmaceuticals Inc · Operating Expenses

AVIR logo

AVIR Operating Expenses

Latest reported$145.27M
AVIR TTM Operating Expenses ($14.60M → $145.27M)
High-resolution chart · PNG

AVIR operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
145,270,000
149,097,000
136,794,000
120,782,000
130,728,000
138,614,000
172,715,000
180,262,000
185,709,000
157,996,000
100,909,000
79,621,000
73,176,000
86,372,000
86,299,000
74,306,000
69,964,000
49,570,000
45,787,000
46,739,000
38,828,000
29,175,000
24,457,000
15,062,000
14,803,000
16,273,000
14,604,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.